{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:29:14Z","timestamp":1765758554857,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jmii.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T20:19:35Z","timestamp":1557346775000},"page":"936-945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan"],"prefix":"10.1016","volume":"53","author":[{"given":"Wang-Da","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Chen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-5916","authenticated-orcid":false,"given":"Ming-Chieh","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristine","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Jhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2019.03.008_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12981-016-0111-1","article-title":"Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question","volume":"13","author":"Eholi\u00e9","year":"2016","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jmii.2019.03.008_bib2","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0140-6736(00)02388-6","article-title":"Hit HIV-1 hard, but only when necessary","volume":"355","author":"Harrington","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.03.008_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/586713","article-title":"Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study","volume":"197","author":"Emery","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/QAD.0b013e32833c703e","article-title":"Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells\/microl is associated with improved treatment outcomes in South Africa","volume":"24","author":"Fox","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2019.03.008_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/377606","article-title":"When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells\/microL","volume":"37","author":"Kaplan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00002030-200105250-00006","article-title":"When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study","volume":"15","author":"Cozzi Lepri","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2019.03.008_bib7","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","article-title":"Effect of early versus deferred antiretroviral therapy for HIV on survival","volume":"360","author":"Kitahata","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2019.03.008_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretroviral and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2019.03.008_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2019.03.008_bib11","first-page":"1","article-title":"Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the national institutes of health, and the HIV medicine association\/infectious diseases society of America","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.jmii.2019.03.008_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(06)69152-6","article-title":"HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis","volume":"368","author":"May","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.03.008_bib13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(03)14570-9","article-title":"Determinants of survival following HIV-1 seroconversion after the introduction of HAART","volume":"362","author":"Porter","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.03.008_bib14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/QAD.0b013e3283112b77","article-title":"HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies","volume":"22","author":"Monforte","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2019.03.008_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.03.008_bib16","doi-asserted-by":"crossref","first-page":"e48839","DOI":"10.1371\/journal.pone.0048839","article-title":"Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy","volume":"7","author":"McManus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.03.008_bib17","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jmii.2019.03.008_bib18","article-title":"Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.03.008_bib19","doi-asserted-by":"crossref","first-page":"e64459","DOI":"10.1371\/journal.pone.0064459","article-title":"Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study","volume":"8","author":"Velen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.03.008_bib20","first-page":"189","article-title":"Zidovudine- versus tenofovir-based antiretroviral therapy for the initial treatment of HIV infection in the ethnic minority region of Liangshan Prefecture, Sichuan Province, China","volume":"16","author":"Cheung","year":"2017","journal-title":"J Int Assoc Phys AIDS Care"},{"key":"10.1016\/j.jmii.2019.03.008_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/tmi.12509","article-title":"Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?","volume":"20","author":"Labhardt","year":"2015","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jmii.2019.03.008_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/cid\/cir1034","article-title":"A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy","volume":"54","author":"Tang","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14059","article-title":"Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection","author":"Tsai","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jmii.2019.03.008_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/liv.14000","article-title":"Liver decompensation in HIV\/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection","volume":"39","author":"Lieveld","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jmii.2019.03.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3702740","article-title":"Tenofovir-based highly active antiretroviral therapy is associated with superior CD4 T cells repopulation compared to zidovudine-based HAART in HIV 1 infected adults","volume":"2018","author":"Badii","year":"2018","journal-title":"Int J Chronic Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12981-017-0132-4","article-title":"Immunological outcomes of tenofovir versus zidovudine-based regimens among people living with HIV\/AIDS: a two years retrospective cohort study","volume":"14","author":"Ayele","year":"2017","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jmii.2019.03.008_bib27","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1097\/QAD.0000000000002010","article-title":"CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era","volume":"32","author":"Roul","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2019.03.008_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cid\/ciu261","article-title":"Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients","volume":"59","author":"Ingle","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2019.03.008_bib29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(09)60612-7","article-title":"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies","volume":"373","author":"Sterne","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.03.008_bib30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/QAD.0b013e32832e9b78","article-title":"Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy","volume":"23","author":"Marin","year":"2009","journal-title":"AIDS"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219300428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219300428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:25:23Z","timestamp":1761657923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118219300428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1684118219300428"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2019.03.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}